Icelandic Medicines Agency
Quality and safety of medicines and medical devices for patients and the general public
News
Access to Drugs that are not on the Icelandic Market
Guidelines have been issued to clarify the different processes that provide access to drugs that are not marketed in Iceland or do not have marketing authorization in the EEA. Among other things, it discusses compassionate use (CU) and named patient use (NPP).
Adverse reactions are harmful and unintended or undesirable effects of the drug. Anyone can report a side effect of a medicine to the Icelandic Medicines Agency!
75
Pharmacies
The Icelandic Medicines Control Agency supervises all pharmacies and pharmacies as well as their branches.
2.919
Medicines on market
Medicines can be placed on the market after receiving a marketing authorization from the Icelandic Medicines Agency.
3.720
Number of packages in the price list
Number of packages that are currently on the market and available in Iceland